Clinical Compound Improves Outcomes in SMA Mouse Models & Michael Talks About His Spinraza Injection

Mar 04, 2019, 12:00 AM

We discuss how a new compound improves clinical outcomes in mouse models of SMA. Also, SMA News Today’s Director of Multichannel Content, Michael Morale, shares his perspectives on his upcoming maintenance dose injection of Spinraza.

Are you interested in understanding gene therapy? ExploreGeneTherapy.com has helpful information about gene therapy, including its history and how it is being investigated for the treatment of genetic diseases. Visit www.exploregenetherapy.com

We discuss how a new compound improves clinical outcomes in mouse models of SMA. Also, SMA News Today’s Director of Multichannel Content, Michael Morale, shares his perspectives on his upcoming maintenance dose injection of Spinraza. Are you interested in understanding gene therapy? ExploreGeneTherapy.com has helpful information about gene therapy, including its history and how it is being investigated for the treatment of genetic diseases. Visit www.exploregenetherapy.com